Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00682_DB01026_nanopub.RA7XDmBuzZiAJqPFbxbxAt9MDPSv0gbsHt1B9vIa5XQIs#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00682_DB01026 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00682_DB01026 label "DDI between Warfarin and Ketoconazole - Ketoconazole, a strong CYP2C9 inhibitor, may decrease the metabolism of warfarin. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of warfarin if ketoconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00682_DB01026]" assertion.
- drugbank_resource:DB00682_DB01026 identifier "drugbank_resource:DB00682_DB01026" assertion.
- drugbank_resource:DB00682_DB01026 title "DDI between Warfarin and Ketoconazole - Ketoconazole, a strong CYP2C9 inhibitor, may decrease the metabolism of warfarin. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of warfarin if ketoconazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB00682 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00682_DB01026 assertion.
- drugbank:DB01026 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00682_DB01026 assertion.